10x Genomics and CHUV team up to find cancer biomarkers predicting treatment success using advanced single cell tech

10x Genomics has partnered with Lausanne University Hospital (CHUV) to research biomarkers that predict cancer treatment responses using 10x's single cell and spatial biology platforms. This multi-year collaboration focuses on analyzing tumor samples from advanced cancer patients to improve personalized treatment decisions and diagnostic tools. The study will cover multiple cancer types, integrating biological data with clinical outcomes to understand treatment resistance and response. The partnership aims to enhance precision oncology by developing biomarkers that guide therapy choices and support clinical decision-making.